Viking Global Investors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-966,139	Closed	-$115M	–	106
2022 Q1	$115M	Buy	966,139 +617,356	+177%	+$73.2M	0.46%	58
2021 Q4	$48.1M	Buy	+348,783	New	+$48.1M	0.14%	87